Our Technologies

We aim to generate multiple high-value new microbiome and probiotic approaches to treat and reduce risk of infections and chronic diseases respectively. To reach this we can rely on our expertise, our employees and our proprietary knowledge and technologies.

 Our proprietary technology platform MicroSIS allows us to screen the microbiome for natural microorganisms displaying specific properties.

Our proprietary technology platform MicroLoad is a microbial display system that allows the presentation of structures on the surface of bacteria without need for genetic modifications.